Charles Lee Sr Nuzum Predictive Oncology Inc. (POAI) insider trading activity

Charles Lee Sr Nuzum is Director of Predictive Oncology Inc.. Currently has a direct ownership of 94,587 shares of POAI, which is worth approximately $612,923. The most recent transaction as insider was on Sep 09, 2025, when has been sold 64,680 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.6K

0% 3M change

196.32% 12M change

Total Value Held $612,923

Charles Lee Sr Nuzum Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 09 2025	BUY Grant, award, or other acquisition	-	64,680 Added 40.61%	94,587 Common Stock
Apr 05 2024	BUY Grant, award, or other acquisition	-	3,268 Added 9.29%	31,921 Common Stock
Oct 02 2023	BUY Grant, award, or other acquisition	-	2,605 Added 8.91%	26,638 Common Stock
Sep 25 2023	SELL Open market or private sale	$30,400 $3.04 p/Share	10,000 Reduced 29.38%	24,033 Common Stock
Jul 03 2023	BUY Grant, award, or other acquisition	-	3,773 Added 9.98%	34,033 Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	-	25,499 Added 4.04%	605,203 Common Stock
Jan 25 2023	BUY Grant, award, or other acquisition	-	53,539 Added 8.45%	579,704 Common Stock

Jan 03 2023	BUY Grant, award, or other acquisition	-	172,150 Added 24.65%	526,165 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	-	23,147 Added 6.14%	354,015 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	44,704 Added 11.9%	330,868 Common Stock
May 20 2022	BUY Open market or private purchase	$62,000 $0.31 p/Share	200,000 Added 41.14%	286,164 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	8,530 Added 9.01%	86,164 Common Stock
Jan 04 2022	BUY Grant, award, or other acquisition	-	43,775 Added 36.06%	77,634 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	6,265 Added 15.61%	33,859 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	13,995 Added 33.65%	27,594 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	-	6,887 Added 33.62%	13,599 Common Stock

CLS

Charles Lee Sr Nuzum

Director

Novato, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells POAI shares.

Notify only if

Value

Insider Trading

Get notified when an Predictive Oncology Inc. insider buys or sells POAI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Predictive Oncology Inc.

Track Activities on POAI

Account